$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

(Karunagappally, India, 1991-1997 cases followed-up until 1999)

Click on cancer site (ICD-10 code) for comparison
Site ICD-10 No. of cases included Complete FUIncomplete FU: loss to FU% with Complete FU at 5 yearsMedian FU (in months)
Alive/deadAt end of FUNo.%% lost to FU: years from diagnosis
No.%<11-33-5>5
C01-02Tongue868497.722.31.20.01.20.097.715.6
C03-06Oral cavity12311996.743.31.60.80.80.096.718.7
C12-13Hypopharynx333193.926.16.10.00.00.093.912.6
C15Oesophagus10610599.110.90.90.00.00.099.16.5
C16Stomach7777100.000.00.00.00.00.0100.05.1
C19-20Rectum3838100.000.00.00.00.00.0100.032.0
C22Liver545398.111.91.90.00.00.098.13.5
C25Pancreas4141100.000.00.00.00.00.0100.04.0
C32Larynx464597.812.20.02.20.00.097.817.6
C33-34Lung22021798.631.41.40.00.00.098.65.2
C44Other skin272592.627.43.70.03.70.092.659.0
C50Breast19018898.921.10.50.00.00.599.536.1
C53Cervix17016999.410.60.00.60.00.099.438.5
C56Ovary3535100.000.00.00.00.00.0100.020.3
C61Prostate322990.639.46.33.10.00.090.634.0
C67Urinary bladder383797.412.62.60.00.00.097.418.6
C70-72Brain & nervous system464597.812.20.02.20.00.097.819.9
C73Thyroid747398.611.41.40.00.00.098.657.0
C82-85+C96Non-Hodgkin lymphoma6969100.000.00.00.00.00.0100.012.1
C90Multiple myeloma282796.413.63.60.00.00.096.417.4
C91Lymphoid leukaemia3838100.000.00.00.00.00.0100.020.3
C92-94Myeloid leukaemia3030100.000.00.00.00.00.0100.02.9


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Karunagappally, India, 1991-1997 cases followed-up until 1999)
- Table5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Karunagappally, India, 1991-1997)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)